Nantahala Capital Management, LLC - Significant Ownership

Signature - Title
Taki Vasilakis - Chief Compliance Officer
Location
New Canaan, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Nantahala Capital Management, LLC.

Significant Ownership of Nantahala Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XTNT Xtant Medical Holdings, Inc. Common Stock, par value $0.000001 per share 49.1% $36.9M $30.8M 68.4M +500% Nantahala Capital Management, LLC Apr 10, 2025
EGRX Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 38.08% $6.43M 4.95M Nantahala Capital Management, LLC Feb 16, 2025
EVOK EVOKE PHARMA, INC. Common Stock, par value $0.0001 per share 15.99% $102K 255K Nantahala Capital Management, LLC Feb 3, 2025
TLPH TALPHERA, INC. Common Stock, par value $0.001 per share 11.7% $1.12M 1.99M Nantahala Capital Management, LLC Mar 31, 2025
SLNO SOLENO THERAPEUTICS, INC. Common Stock, $0.001 par value 9.99% $213M 4.35M Nantahala Capital Management, LLC Dec 31, 2024
VSTM Verastem, Inc. Common Stock, $0.0001 par value per share 9.99% $32.6M $3.4M 4.52M +11.6% Nantahala Capital Management, LLC Dec 31, 2024
ABEO ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value 9.99% $24.2M 4.43M Nantahala Capital Management, LLC Sep 30, 2024
TELA TELA Bio, Inc. Common Stock, $0.001 par value per share 9.99% $10.7M $5.54M 3.97M +108% Nantahala Capital Management, LLC Dec 31, 2024
ELUT Elutia Inc. Class A Common Stock, par value $0.001 per share 9.99% $9.7M 2.98M Nantahala Capital Management, LLC Sep 30, 2024
VTGN VISTAGEN THERAPEUTICS, INC. Common Stock, par value $0.001 per share 9.99% $7.91M 2.83M Nantahala Capital Management, LLC Sep 30, 2024
NSPR InspireMD, Inc. Common Stock, par value $0.0001 per share 9.99% $7.78M 2.71M Nantahala Capital Management, LLC Dec 31, 2024
UNCY UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share 9.99% $6.42M 10.9M Nantahala Capital Management, LLC Dec 19, 2024
OPTN OPTINOSE, INC. Common stock, par value $0.001 per share 9.99% $5.9M 15.1M Nantahala Capital Management, LLC Sep 30, 2024
OPTN OPTINOSE, INC. Common stock, par value $0.001 per share 9.99% $5.44M -$76.3M 1.01M -93.4% Nantahala Capital Management, LLC Dec 31, 2024
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 9.99% $4.05M $46.6K 339K +1.16% Nantahala Capital Management, LLC Dec 31, 2024
APYX APYX MEDICAL CORPORATION Common Stock 9.99% $3.67M 3.49M Nantahala Capital Management, LLC Dec 31, 2024
DRIO DarioHealth Corp. Common Stock, par value $0.0001 per share 9.99% $2.56M 3.51M Nantahala Capital Management, LLC Dec 31, 2024
SNTI Senti Biosciences, Inc. Common stock, par value $0.0001 per share 9.99% $1.71M 509K Nantahala Capital Management, LLC Dec 31, 2024
PHGE BiomX Inc. Common stock, $0.0001 par value 9.99% $1.08M 1.79M Nantahala Capital Management, LLC Sep 30, 2024
KPRX KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value 9.99% $1.01M 306K Nantahala Capital Management, LLC Sep 30, 2024
NDLS NOODLES & COMPANY Class A Common Stock, $0.01 par value per share 9.88% $5.5M 4.51M Nantahala Capital Management, LLC Sep 30, 2024
SSKN STRATA SKIN SCIENCES, INC. Common Stock, $0.001 Par Value 9.68% $1.07M 404K Nantahala Capital Management, LLC Sep 30, 2024
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 9.65% $13.8M 1.04M Nantahala Capital Management, LLC Sep 30, 2024
ASRT ASSERTIO HOLDINGS, INC. Common Stock, $0.0001 par value 9.39% $7.16M 8.95M Nantahala Capital Management, LLC Sep 30, 2024
RMBL RumbleOn, Inc. Class B Common Stock, $0.001 par value 8.69% $12.3M 3.07M Nantahala Capital Management, LLC Sep 30, 2024
ANEB ANEBULO PHARMACEUTICALS, INC. Common Stock 8.63% $4.9M 3.55M Nantahala Capital Management, LLC Dec 31, 2024
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A. Common Stock, $1.00 par value 7.82% $1.77M 2.13M Nantahala Capital Management, LLC Dec 31, 2024
CRMT AMERICA'S CAR-MART, INC. Common Stock, par value $0.01 per share 7.8% $29M 645K Nantahala Capital Management, LLC Mar 10, 2025
FULC FULCRUM THERAPEUTICS, INC. Common stock, par value $0.001 per share 7.66% $18.3M 4.78M Nantahala Capital Management, LLC Sep 30, 2024
IKT INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value 7.54% $11.7M 5.3M Nantahala Capital Management, LLC Dec 31, 2024
EB EVENTBRITE, INC. Class A common stock, $0.00001 par value 7.3% $14.8M 5.93M Nantahala Capital Management, LLC Dec 31, 2024
APRE Aprea Therapeutics, Inc. Common stock, par value $0.001 per share 7.3% $996K 412K Nantahala Capital Management, LLC Sep 30, 2024
NVNO enVVeno Medical Corporation Common Stock, $0.00001 par value 7.06% $3.69M 1.29M Nantahala Capital Management, LLC Sep 30, 2024
TITN TITAN MACHINERY INC. Common Stock, $0.00001 par value per share 7.03% $23.6M 1.63M Nantahala Capital Management, LLC Sep 30, 2024
STKS ONE GROUP HOSPITALITY, INC. Common Stock 6.77% $5.28M $1.02M 2.09M +23.9% Nantahala Capital Management, LLC Dec 31, 2024
BVS BIOVENTUS INC. Class A Common Stock, $0.001 par value per share 6.69% $47M 4.35M Nantahala Capital Management, LLC Sep 30, 2024
EHTH EHEALTH, INC. Common Stock, par value $0.001 per share 6.5% $14.6M 1.91M Nantahala Capital Management, LLC Sep 30, 2024
FOSL FOSSIL GROUP, INC. Common Stock, par value $0.01 per share 6.25% $5.46M 3.33M Nantahala Capital Management, LLC Dec 31, 2024
QURE uniQure N.V. Ordinary Shares, par value 0.05 EUR 6.12% $37.3M 2.98M Nantahala Capital Management, LLC Sep 30, 2024
ESTA Establishment Labs Holdings Inc. Common Shares, No Par Value 6.1% $60.2M 1.68M Daniel Mack Dec 31, 2024
THTX THERATECHNOLOGIES INC. Common Shares 5.83% $4.08M 2.68M Nantahala Capital Management, LLC Sep 30, 2024
CLRB Cellectar Biosciences, Inc. Common stock, par value $0.00001 5.73% $777K 2.51M Nantahala Capital Management, LLC Dec 31, 2024
CONNQ CONNS, INC. Common Stock, par value $0.01 per share 5.58% $41.7K -$26.2K 1.39M -38.6% Nantahala Capital Management, LLC Dec 31, 2024
IMAX IMAX Corporation Common Shares, no par value 5.28% $69M 2.78M Nantahala Capital Management, LLC Sep 30, 2024
GAIA GAIA, INC Class A Common Stock 5.06% $5.2M 915K Nantahala Capital Management, LLC Sep 30, 2024
RZLT REZOLUTE, INC. Common Stock, par value $0.001 per share 4.93% $10.7M 2.86M Nantahala Capital Management, LLC Dec 31, 2024
DHX DHI Group, Inc. Common Stock, par value $0.01 per share 4.91% $5.2M 2.38M Nantahala Capital Management, LLC Sep 30, 2024
EOLS EVOLUS, INC. Common Stock, par value $0.00001 per share 4.48% $39.4M 2.82M Nantahala Capital Management, LLC Sep 30, 2024
BKSY BLACKSKY TECHNOLOGY INC. Class A common stock, par value $0.0001 per share 4.47% $12.1M -$9.44M 1.38M -43.8% Nantahala Capital Management, LLC Dec 31, 2024
ZVRA ZEVRA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 4.38% $18.5M 2.34M Nantahala Capital Management, LLC Dec 31, 2024
CDXS Codexis, Inc. Common Stock, par value $0.0001 per share 4.26% $12.3M 2.97M Nantahala Capital Management, LLC Sep 30, 2024
PTON Peloton Interactive, Inc. Class A common stock, $0.000025 par value per share 3.39% $70.7M -$36.3M 12.3M -33.9% Nantahala Capital Management, LLC Dec 31, 2024
RDVT RED VIOLET, INC. Common Stock, $0.001 par value per share 3.3% $17.6M 452K Nantahala Capital Management, LLC Sep 30, 2024
VMD Viemed Healthcare, Inc. Common Shares, no par value 2.92% $8.87M 1.14M Nantahala Capital Management, LLC Sep 30, 2024
IMAX Corporation Common Shares, no par value 2.66% 1.4M -49.6% Nantahala Capital Management, LLC Dec 31, 2024
NMTC NeuroOne Medical Technologies Corporation Common stock, $0.001 par value 2.59% $911K 799K Nantahala Capital Management, LLC Sep 30, 2024
LXFR Luxfer Holdings PLC Ordinary Shares, nominal value 0.50 GBP each 1.55% $4.97M 414K Nantahala Capital Management, LLC Sep 30, 2024
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share 1.06% $126K 702K Nantahala Capital Management, LLC Sep 30, 2024

Schedules 13D/G Reported by Nantahala Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.